Isolate-Based Surveillance of Bordetella pertussis, Austria, 2018-2020
- PMID: 33622477
- PMCID: PMC7920692
- DOI: 10.3201/eid2703.202314
Isolate-Based Surveillance of Bordetella pertussis, Austria, 2018-2020
Abstract
Pertussis is a vaccine-preventable disease, and its recent resurgence might be attributable to the emergence of strains that differ genetically from the vaccine strain. We describe a novel pertussis isolate-based surveillance system and a core genome multilocus sequence typing scheme to assess Bordetella pertussis genetic variability and investigate the increased incidence of pertussis in Austria. During 2018-2020, we obtained 123 B. pertussis isolates and typed them with the new scheme (2,983 targets and preliminary cluster threshold of <6 alleles). B. pertussis isolates in Austria differed genetically from the vaccine strain, both in their core genomes and in their vaccine antigen genes; 31.7% of the isolates were pertactin-deficient. We detected 8 clusters, 1 of them with pertactin-deficient isolates and possibly part of a local outbreak. National expansion of the isolate-based surveillance system is needed to implement pertussis-control strategies.
Keywords: Austria; Bordetella pertussis; acellular vaccines; bacteria; cgMLST; clusters; core-genome multilocus sequence typing; respiratory infections; surveillance; vaccine-preventable diseases; vaccines.
Figures
Similar articles
-
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.Emerg Infect Dis. 2021 Jun;27(6):1561-1566. doi: 10.3201/eid2706.203850. Emerg Infect Dis. 2021. PMID: 34014152 Free PMC article. Review.
-
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.Emerg Infect Dis. 2019 Nov;25(11):2048-2054. doi: 10.3201/eid2511.190329. Emerg Infect Dis. 2019. PMID: 31625838 Free PMC article.
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
-
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.Emerg Infect Dis. 2014 Apr;20(4):626-33. doi: 10.3201/eid2004.131478. Emerg Infect Dis. 2014. PMID: 24655754 Free PMC article.
-
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.Clin Vaccine Immunol. 2014 Feb;21(2):119-25. doi: 10.1128/CVI.00717-13. Epub 2013 Nov 20. Clin Vaccine Immunol. 2014. PMID: 24256623 Free PMC article.
Cited by
-
Whole-Genome Analysis of Bordetella pertussis MT27 Isolates from School-Associated Outbreaks: Single-Nucleotide Polymorphism Diversity and Threshold of the Outbreak Strains.Microbiol Spectr. 2023 Jun 15;11(3):e0406522. doi: 10.1128/spectrum.04065-22. Epub 2023 May 16. Microbiol Spectr. 2023. PMID: 37191540 Free PMC article.
-
Real-Time Nanopore Q20+ Sequencing Enables Extremely Fast and Accurate Core Genome MLST Typing and Democratizes Access to High-Resolution Bacterial Pathogen Surveillance.J Clin Microbiol. 2023 Apr 20;61(4):e0163122. doi: 10.1128/jcm.01631-22. Epub 2023 Mar 29. J Clin Microbiol. 2023. PMID: 36988494 Free PMC article.
-
Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.Expert Rev Vaccines. 2022 Jul;21(7):899-907. doi: 10.1080/14760584.2021.1984891. Epub 2021 Oct 8. Expert Rev Vaccines. 2022. PMID: 34555994 Free PMC article.
References
-
- Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, et al.; Clinical Validation Study Group. Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT). PLoS One. 2018;13:e0195979. 10.1371/journal.pone.0195979 - DOI - PMC - PubMed
-
- Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Codina G, Cornejo-Sánchez T, Rajadell M, et al. Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015. Emerg Microbes Infect. 2019;8:1711–20. 10.1080/22221751.2019.1694395 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical